Metrics as of 10/16/2026, 02:15 AM (Berlin time), refresh in progress.
CVRx Stock
CVRx, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Kevin Hykes
- Employees
- 223
- Market cap
- $35 M
- IPO
- 30/06/2021
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms…
CVRx stock: price history
1D
-6.5%
1W
-17.7%
1M
-57.0%
6M
-82.3%
YTD
-81.7%
1Y
-86.3%
2Y
-84.4%
5Y
-91.7%
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~87% stronger price swings than usual
Ask the agents about CVRx
Analyst assessment of CVRx
PRICE TARGET LOW
US$3.50
CONSENSUS
US$4.30
MEDIAN
US$4.00
PRICE TARGET HIGH
US$5.00
0
STRONG BUY
5
BUY
1
HOLD
1
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 17/08/2026
CVRx stock metrics
P/E
-0.66
P/B
1.73
EV/EBITDA
-0.71
RETURN ON EQUITY
-70.4%
NET MARGIN
-89.4%
DEBT/EQUITY
2.98
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
60.8%
FLOAT SHARES
16,200,890
AVG. DAILY VOLUME (30D)
721,823
Insider transactions (SEC)
Binkowski Brent
Binkowski Brent
Nielsen Kirk G.
Ballinger Kevin J.
DALE MICHAEL D
Institutional holders
Comparable stocks
Frequently asked questions about CVRx stock
What does CVRx do?
CVRx, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Kevin Hykes, the company employs around 223 people.
The IPO was on 30/06/2021; the stock trades on NASDAQ under the ticker CVRX.
What do analysts say about CVRx stock?
7 analysts rate the stock, the consensus is Buy (as of 17/08/2026).
The average price target is US$4.30, ranging from US$3.50 to US$5.00, with a median of US$4.00.
This is an external assessment, not a statement by Market Jury.
When does CVRx report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 87% stronger than usual.
Does CVRx pay a dividend?
No, CVRx currently does not pay a dividend.
Which stocks are comparable to CVRx?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get CVRx stock analyzed?
Clicking "Analyze stock" lets five strategies assess CVRx against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.